(+)-纳洛酮
伤害
类阿片
药理学
背景(考古学)
化学
受体
阿片受体
医学
生物
生物化学
古生物学
作者
Geissy I.M.C. Feitosa,Isabella Fernandes Carvalho,Edivaldo B.S. Coelho,Marla Rochana Braga Monteiro,Rafael L. Medeiros,Ellaine Dóris Fernandes Carvalho,Paulo T. A. Silva,Dóris M.F. Carvalho,Daniel E. A. Uchôa,Edilberto R. Silveira,Cláudia Ferreira Santos,Nilberto Robson Falcão do Nascimento,Maria-Denise F. Carvalho,Bruno A. Cardi,Krishnamurti M. Carvalho
出处
期刊:Pain reports
[Wolters Kluwer]
日期:2019-10-10
卷期号:4 (6): e791-e791
被引量:3
标识
DOI:10.1097/pr9.0000000000000791
摘要
INTRODUCTION: In recent decades, several researches have been conducted in search of new analgesics that do not present the side effects of opioids. In this context, animal venoms contain natural painkillers that have been used for the development of new analgesics. OBJECTIVE: venom, in murine acute pain models, and to verify the participation of the opioid system in these effects. METHODS: ) 20 minutes before TCB administration. In addition, the TCB action on the μ, δ, and κ opioid receptors was performed by radioligand binding assays. RESULTS: (p.o.). Naloxone did not alter the effect of TCB. In addition, TCB did not act on the μ, δ, and κ opioid receptors. CONCLUSION: The results suggest that TCB may represent a novel potential nonopioid therapeutic analgesic for treatment of acute pains.
科研通智能强力驱动
Strongly Powered by AbleSci AI